Expand CRVS Menu
CRVS MENU

Corvus Pharmaceuticals (CRVS)'s 30-day implied volatility (IV30) was 65.6% at the close on November 4, 2026, down from 71.3% the day before, against a 52-week range of 44.8% to 191.3%. Its 20-day historical volatility was 60.6%.

Key numbers
  • 30-day implied volatility (IV30): 65.6%
  • IV30 52-week range: 44.8% to 191.3% (median 80.2%)
  • Historical volatility: 20-day 60.6%, 1-year 72.8%
  • Implied move by the nearest expiration: ±5.4%

Data as of November 4, 2026.

CRVS Implied Volatility (IV) vs Historical Volatility (HV)

Market Data Delayed 15 Minutes